# A Novel Treatment for Metastatic Melanoma

> **NCT00758797** · PHASE1 · TERMINATED · sponsor: **Northwestern University** · enrollment: 7 (actual)

## Conditions studied

- Metastatic Melanoma

## Interventions

- **OTHER:** Photoimmunotherapy

## Key facts

- **NCT ID:** NCT00758797
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Study was not renewed during annual Northwestern Cancer Center review.
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00758797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00758797, "A Novel Treatment for Metastatic Melanoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00758797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*